J, C., B, P., X, C., Y, L., Z, T., C, M., & J, G. (2026). An emerging targeted strategy for gastric cancer: The multi-pathway regulatory potential of Chinese medicine monomers. Frontiers in oncology, 16, 1795543. https://doi.org/10.3389/fonc.2026.1795543
Chicago Style (17th ed.) CitationJ, Chen, Pan B, Cao X, Li Y, Tu Z, Ma C, and Guo J. "An Emerging Targeted Strategy for Gastric Cancer: The Multi-pathway Regulatory Potential of Chinese Medicine Monomers." Frontiers in Oncology 16 (2026): 1795543. https://doi.org/10.3389/fonc.2026.1795543.
MLA (9th ed.) CitationJ, Chen, et al. "An Emerging Targeted Strategy for Gastric Cancer: The Multi-pathway Regulatory Potential of Chinese Medicine Monomers." Frontiers in Oncology, vol. 16, 2026, p. 1795543, https://doi.org/10.3389/fonc.2026.1795543.